目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Information Sources
Research Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for Protein Drugs, by Type, Through 2026
Figure Summary : Global Market for Protein Drugs, by Type, 2019-2026

Chapter- 3: Therapeutic Proteins: Overview
History
Pharmacological Classification of Therapeutic Proteins
Molecular Classification of Therapeutic Proteins
Manufacturing Technologies

Chapter- 4: Regulatory Aspects
Monoclonal Antibodies
Therapeutic Enzymes
Cytokines
Peptide Hormones
Vaccines
Blood Products
Peptide Antibiotics
Recalls and Safety Alerts

Chapter- 5: New Developments
Monoclonal Antibodies
Vaccines
Cytokines
Peptide Hormones
Therapeutic Enzymes
Blood Products
Peptide Antibiotics

Chapter- 6: Market Analysis of Protein Drugs by Type
Global Market for Protein Drugs by Type

Chapter- 7: Market Analysis of Protein Drugs by Region
Global Market for Protein Drugs by Region

Chapter- 8: Market Analysis of Protein Drugs by Manufacturing Process
Global Market for Protein Drugs by Manufacturing Process

Chapter- 9: Competitive Landscape
Mergers and Acquisitions
Monoclonal Antibodies
Peptide Hormones
Vaccines
Blood Factors
Cytokines
Therapeutic Enzymes
Peptide Antibiotics

Chapter- 10: Market Dynamics
Market Drivers
Market Challenges
Impact of COVID-19 on Protein Drugs Market

Chapter- 11: Patent Analysis

Chapter- 12: Company Profiles
ABBVIE INC.
ALEXION PHARMACEUTICALS
AMGEN INC.
APOTEX INC.
BAYER PHARMACEUTICALS
BIOGEN
BIOMARIN PHARMACEUTICAL INC.
BRISTOL-MYERS SQUIBB
BIOTEST
CSL LTD.
ELI LILLY
F. HOFFMANN-LA ROCHE AG
FRESENIUS KABI
GLAXOSMITHKLINE
GRIFOLS S.A.
JOHNSON & JOHNSON
MERCK & CO., INC.
MERCK KGAA
NOVO NORDISK AG
NOVARTIS AG
OCTAPHARMA AG
PFIZER INC.
SANDOZ
SANOFI S.A.
SEAGEN
TAKEDA PHARMACEUTICAL CO., LTD.
UCB CO.